Previous 10 | Next 10 |
In a statement , Bristol-Myers Squibb (NYSE: BMY ) says its takeover of Celgene (NASDAQ: CELG ) "remains on track" to close in Q3. More news on: Bristol-Myers Squibb Company, Celgene Corporation, Healthcare stocks news, Merger & acquisition news, Read more ...
The U.S. Supreme Court has rejected the state of Maryland's appeal of an appeals court ruling that struck down its anti-price gouging law citing the illegality of state-level regulation of interstate commerce. More news on: Health Care Select Sect SPDR ETF, iShares Nasdaq Biotechnology E...
Merger activity decreased last week with two new deals announced and five pending deals closing. Deal Statistics: New Deals: The acquisition of Ellie Mae (ELLI) by Thoma Bravo for $3.7 billion or $99.00 per share in cash. The acquisition of CAS Medical Systems (CASM) by Edwar...
Introduction - Teva ( TEVA ) versus branded biotechs TEVA reported Q4 and full-year numbers last week, and the stock sank sharply, with its ADS closing at $17.98 Friday. Using the 1.10 B fully diluted shares the company guided for the present period on the c onference call , that puts its ...
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology looks undervalued by a bit more than 10% relative to historical avera...
Activist hedge fund Starboard Value has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb (NYSE: BMY ) shareholders for its $74B deal to buy Celgene (NASDAQ: CELG ), Reuters reports . More news on: Bristol-Myers Squibb Company, Celgene Corporation, Merger &a...
A vast majority of our articles are based on conservative or income-oriented strategies mostly focused on retirees, near-retirees, or folks who are within 10-20 years of their retirement. This article is a bit of an outlier and focused on investing in fast-growing companies. However, rather th...
In (yet another) statement , FDA Commission Scott Gottlieb, M.D. announces the issuance of final updated guidance for gene therapy and cell therapy developers. More news on: Abeona Therapeutics Inc., Bellicum Pharmaceuticals, ZIOPHARM Oncology, Inc., Healthcare stocks news, Read more ...
In a statement , FDA commissioner Scott Gottlieb, M.D. announces a new pathway for accelerated view of marketing applications from generic drugmakers for off-patent branded medicines facing no generic competition, a situation characterizing "hundreds" of such drugs that serve small patient ...
Biotech Pulse Biotech tumbled off a steep ski slope in the last quarter, and at the December low, the Nasdaq Biotechnology Index ( IBB ) had declined -28%, while the S&P Biotech Select Index ( XBI ) a whopping -36%. But it seems biotechs were able to regain their composure at the lows an...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...